Certified by Founder
Lodge
Phialogics - The immune tolerance company
start up
Germany
- Frankfurt, Hesse
- 08/05/2023
- Pre-Seed
- $662,970
Our immune checkpoint activators protect patient’s organ tissue.
Unique approach :
- Potential for BEST-in-class super agonist against immune-mediated tissue damage
- High selectivity for active T-cells
- Proof of concept in relevant human in vitro models and mouse model of disease
- Industry Biotechnology Research
- Website https://www.phialogics.com/
- LinkedIn https://www.linkedin.com/company/phialogics/
Related People
Andreas ErnstFounder
Germany -
ND
Expert in protein engineering with a keen interest in drug development for the treatment of autoimmune diseases.
Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)